QCM
AMRX icon

Quantinno Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Quantinno Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$467K Buy
37,599
+10,457
+39% +$140K ﹤0.01% 2759
2025
Q4 		$342K Buy
27,142
+4,460
+20% +$51K ﹤0.01% 2744
2025
Q3 		$227K Buy
22,682
+9,583
+73% +$86K ﹤0.01% 2675
2025
Q2 		$106K Buy
+13,099
New +$98.8K ﹤0.01% 2503

Other funds holding AMRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return